Robert Willett - Feb 18, 2025 Form 4 Insider Report for COGNEX CORP (CGNX)

Role
CEO & President, Director
Signature
Robert Willett
Stock symbol
CGNX
Transactions as of
Feb 18, 2025
Transactions value $
$0
Form type
4
Date filed
2/20/2025, 05:10 PM
Previous filing
May 23, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGNX Common Stock 15.8K Feb 18, 2025 by Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGNX Non-Qualified Stock Option (right to buy) Award $0 +193K $0.00 193K Feb 18, 2025 Common Stock 193K $33.04 Direct F2
transaction CGNX Restricted Stock Unit Award $0 +70.8K $0.00 70.8K Feb 18, 2025 Common Stock 70.8K $0.00 Direct F3, F4
holding CGNX Non-Qualified Stock Option (right to buy) 180K Feb 18, 2025 Common Stock 180K $38.39 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 298K Feb 18, 2025 Common Stock 298K $39.44 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 233K Feb 18, 2025 Common Stock 233K $47.21 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 180K Feb 18, 2025 Common Stock 180K $50.94 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 180K Feb 18, 2025 Common Stock 180K $51.49 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 90K Feb 18, 2025 Common Stock 90K $56.44 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 185K Feb 18, 2025 Common Stock 185K $64.43 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 124K Feb 18, 2025 Common Stock 124K $90.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a trustee and beneficiary of Willett Parkhill Investment Trust dated August 2, 2010. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
F2 The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
F3 Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
F4 The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively.